We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Innovative Fusion Device Could Revolutionize Back Surgery

By HospiMedica International staff writers
Posted on 29 Dec 2015
Print article
Image: The Thru–Fuze device (Photo courtesy of USNW).
Image: The Thru–Fuze device (Photo courtesy of USNW).
A new spinal fusion device designed to reduce chronic back pain could negate the need for invasive surgery and bone grafts.

Under development by researchers at the University of New South Wales (UNSW; Sydney, Australia) the Thru–Fuze device is made of porous titanium that promotes bone growth and fusion both on and through the device after it is placed between the vertebrae. Over time, the device acts as a bridge between adjacent vertebrae for additional bone growth, resulting in rapid biomechanical fixation, without the need for a bone graft procedure or supporting metallic hardware.

According to the researchers, the device will allow faster, simpler surgery with minimal radiation exposure compared to current methods. Preclinical and laboratory testing in animal models has demonstrated rapid biomechanical fixation between the fusion device and the vertebrae. Human trials of the Thru-Fuze are expected to begin at the Prince of Wales Hospital (Sydney, NSW, Australia) in late 2016, with future commercialization of the device exclusively licensed to Intellectual Ventures (Bellvue, WA, USA). Patents for the technology have been filed in Australia, Europe, China, and the United States.

“Existing methods of spinal fusion use rod or cage systems that require screws to be drilled into the spine and a painful bone graft harvested, which is the material used to form the bridge and obtain the fusion between the vertebrae in the spine,” said device inventor Prof. Bill Walsh, MD, director of surgical and orthopedic laboratories at UNSW. “These systems are very costly, difficult and time consuming to implant and they also have variable rates of fusion success. Existing methods rely on the bone to make its way right across the vertebrae and it can take up to a year to find out if the surgery has been a success.”

“New technologies such as the Thru-Fuze are of paramount importance, as surgeons strive to deliver better patient outcomes with less invasive and more effective implant and prostheses options,” said neurosurgeon Ralph Mobbs, MD, who will lead the human trials. “The potential of the device is significant.”

Related Links:

University of New South Wales 
Intellectual Ventures


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
EEG System
BRAIN QUICK

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.